RxDoctor Payments Data

Lainee Goettsche, MD

Dermatology · Sioux Falls, SDNPI 1033647177

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $735 of the $844 with a category attached, or 87.2%. 7 manufacturers reported payments, led by AbbVie at 35.1% of the total. That places this record below the midpoint for dermatology clinicians in SD, where the typical reported total is $1,250.

$844in general payments, 2019–2025

Across 43 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$296
  • Regeneron Healthcare Solutions, Inc.$203
  • Sanofi$202
  • Johnson & Johnson$65
  • AstraZeneca$43
  • Amgen$20
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$73587%
  • Education$10813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$844 in reported general payments places this provider in the 40th percentile of 44 dermatology providers in South Dakota.

See all dermatology providers in South Dakota

Medicare billing

Part B allowed, 2024
$104,175
Medicare patients
552
Services billed
2,474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast47$179,611
Dupixent PenDupilumab25$90,261
Cosentyx Sensoready (2 Pens)Secukinumab13$84,754
Fluorouracil34$2,563
Clobetasol Propionate39$1,871
Fluocinonide23$1,103
Metronidazole18$951
Ketoconazole61$905
Triamcinolone Acetonide94$718
Hydroxychloroquine Sulfate29$617
Doxycycline Monohydrate15$537
MethotrexateMethotrexate Sodium32$456
Hydrocortisone40$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$20$179,61147 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 44 dermatology providers in South Dakota.

Other dermatology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →